SS Innovations International (NASDAQ:SSII) Shares Gap Down - What's Next?

Key Points

• SS Innovations International shares fell at the open, dropping from a prior close of $3.11 to $2.99 before last trading near $3.04 on Friday.
• Analyst sentiment remains negative: the stock carries an average “Sell” rating and a $7.00 average price target, despite one firm upgrading it from “Sell” to “Hold.”
• The company reported a quarterly loss of $0.01 per share on $13.94 million in revenue, alongside negative net margin and return on equity; meanwhile, CEO Srivastava Sudhir sold 33,333 shares for approximately $100,000.

SS Innovations International, Inc. (NASDAQ:SSII - Get Free Report)'s stock price gapped down before the market opened on Friday. The stock had previously closed at $3.11, but opened at $2.99. SS Innovations International shares last traded at $3.0360, with a volume of 6,051 shares changing hands.

Analyst Ratings Changes

SSII has been the subject of several research reports. Wall Street Zen raised SS Innovations International from a "sell" rating to a "hold" rating in a research note on Sunday, June 28th. Loop Capital set a $7.00 target price on SS Innovations International in a research report on Wednesday, June 3rd. Finally, Weiss Ratings reaffirmed a "sell (e+)" rating on shares of SS Innovations International in a report on Friday, July 17th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company presently has an average rating of "Sell" and an average price target of $7.00.

SS Innovations International Stock Up 0.0%

The firm has a 50-day moving average of $3.55 and a two-hundred day moving average of $3.95. The stock has a market capitalization of $591.32 million, a price-to-earnings ratio of -49.18 and a beta of -1.94.

SS Innovations International (NASDAQ:SSII - Get Free Report) last announced its quarterly earnings data on Thursday, August 13th. The company reported ($0.01) EPS for the quarter. The business had revenue of $13.94 million for the quarter. SS Innovations International had a negative return on equity of 26.77% and a negative net margin of 23.73%.

Insider Activity at SS Innovations International

In related news, CEO Srivastava Sudhir sold 33,333 shares of the business's stock in a transaction that occurred on Friday, September 4th. The shares were sold at an average price of $3.00, for a total transaction of $99,999.00. Following the transaction, the chief executive officer directly owned 108,520,928 shares of the company's stock, valued at approximately $325,562,784. The trade was a 0.03% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the stock. IFC & Insurance Marketing Inc. increased its stake in shares of SS Innovations International by 47.7% in the first quarter. IFC & Insurance Marketing Inc. now owns 16,730 shares of the company's stock worth $84,000 after acquiring an additional 5,400 shares during the last quarter. Handelsbanken Fonder AB boosted its position in SS Innovations International by 9.3% during the fourth quarter. Handelsbanken Fonder AB now owns 120,000 shares of the company's stock valued at $682,000 after purchasing an additional 10,198 shares during the last quarter. Inspire Investing LLC boosted its position in SS Innovations International by 26.4% during the first quarter. Inspire Investing LLC now owns 104,624 shares of the company's stock valued at $523,000 after purchasing an additional 21,851 shares during the last quarter. Finally, Eversept Partners LP grew its stake in SS Innovations International by 46.2% in the first quarter. Eversept Partners LP now owns 110,157 shares of the company's stock valued at $551,000 after purchasing an additional 34,799 shares in the last quarter.

About SS Innovations International

SS Innovations International, Inc is a medical technology company focused on developing, manufacturing and commercializing robotic-assisted surgical systems. Through its operating business in India, the company offers the SSi Mantra robotic surgery platform, which is designed to support minimally invasive procedures across multiple surgical specialties.

The company's product portfolio includes the SSi Mantra system, robotic instruments and related accessories, as well as surgical training, installation, maintenance and support services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.